Skip to content
Sign in

GH · NASDAQ

Guardant Health (GH) Stock Price & Fundamentals

$366.83+1.02%+$3.70End-of-day price as of Oct 9, 2026

Guardant Health (GH) closed at $366.83 on Oct 9, 2026, up 1.02% from the previous close of $363.13.

Share price, past year

1Y +5.50%

52-week range $318.63 – $371.76. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$366.83
Sep 30, 2026$366.65
Aug 31, 2026$362.35
Jul 31, 2026$348.71
Jun 30, 2026$351.60
May 29, 2026$329.68
Apr 30, 2026$321.38
Mar 31, 2026$344.96
Feb 27, 2026$346.59
Jan 30, 2026$354.63
Dec 31, 2025$346.11
Nov 28, 2025$340.98
Oct 31, 2025$352.11

Key statistics

Market cap
$49.01B
P/E (TTM)
—
EPS (TTM)
−$3.50
Revenue (TTM)
$1.18B
Net income (TTM)
−$453.44M
Shares outstanding
133.6M
Dividend yield
—
52-week range
$318.63 – $371.76

Guardant Health's market cap is $49.01B, based on a share price of $366.83 and 133.6M shares outstanding as of Jun 30, 2026.

Financials

Guardant Health reported revenue of $982.02M for fiscal 2025, up 32.88% from fiscal 2024.

Guardant Health reported a net loss of $416.28M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Guardant Health annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$982.02M+32.9%−$416.28M−42.4%−$3.32−$233.07M
FY2024ended Dec 31, 2024$739.02M+31.0%−$436.37M−59.1%−$3.56−$274.94M
FY2023ended Dec 31, 2023$563.95M+25.5%−$479.45M−85.0%−$4.28−$345.46M
FY2022ended Dec 31, 2022$449.54M+20.3%−$654.59M−145.6%−$6.41−$386.92M
FY2021ended Dec 31, 2021$373.65M+30.3%−$384.77M−103.0%−$4.00−$284.05M
FY2020ended Dec 31, 2020$286.73M+33.8%——−$2.60−$140.10M
FY2019ended Dec 31, 2019$214.38M+136.5%−$75.65M−35.3%−$0.84−$65.85M
FY2018ended Dec 31, 2018$90.64M+81.9%−$85.06M−93.9%−$2.80−$92.39M
FY2017ended Dec 31, 2017$49.84M+97.4%−$83.22M−167.0%−$7.07−$78.92M
FY2016ended Dec 31, 2016$25.25M—−$46.14M−182.7%−$3.53−$38.48M
Guardant Health quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$334.98M−$120.14M−$0.90
Q1 FY2026ended Mar 31, 2026$301.67M−$112.08M−$0.85
Q4 FY2025ended Dec 31, 2025$281.27M−$128.49M−$1.01
Q3 FY2025ended Sep 30, 2025$265.20M−$92.73M−$0.74
Q2 FY2025ended Jun 30, 2025$232.09M−$99.90M−$0.80
Q1 FY2025ended Mar 31, 2025$203.47M−$95.16M−$0.77
Q4 FY2024ended Dec 31, 2024$201.81M−$111.01M−$0.90
Q3 FY2024ended Sep 30, 2024$191.48M−$107.75M−$0.88

Company profile

Name
Guardant Health, Inc.
Ticker
GH
Exchange
NASDAQ
Industry (SEC SIC)
Services-Medical Laboratories
Headquarters
3100 Hanover Street, Palo Alto, CA 94304
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001576280

Recent SEC filings

Frequently asked questions

What is Guardant Health's stock price?

Guardant Health (GH) closed at $366.83 on Oct 9, 2026, up 1.02% from the previous close of $363.13.

What is Guardant Health's market cap?

Guardant Health's market cap is $49.01B, based on a share price of $366.83 and 133.6M shares outstanding as of Jun 30, 2026.

How much revenue does Guardant Health make?

Guardant Health reported revenue of $982.02M for fiscal 2025, up 32.88% from fiscal 2024.

Does Guardant Health pay a dividend?

Guardant Health's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Guardant Health, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures